Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of race on survival in men with metastatic hormone-refractory prostate cancer.

Urology - 1 Aug 2004

Halabi Susan, Small Eric J, Vogelzang Nicholas J, Barrier Robert C, George Stephen L, Gilligan Timothy D

Abstract excerpt

OBJECTIVES: To determine whether blacks with hormone-refractory prostate cancer have shorter survival compared with whites with the same disease. METHODS: Data from eight multicenter trials (four Phase II and four randomized Phase III studies) conducted by the Cancer and Leukemia Group B were combined. Eligible patients had progressive prostate cancer after androgen deprivation therapy (with documented castration...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials, Phase III as Topic
Share to Androgen Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Agents, Hormonal

Share to Clinical Trials, Phase II as Topic

Share to Multicenter Studies as Topic

Share to Prostatectomy

Share to Salvage Therapy

Share to Socioeconomic Factors

Source

Identifiers

PMID: 15302462
DOI: 10.1016/j.urology.2004.04.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Impact of race on survival in men with metastatic hormone-refractory prostate cancer.PMID 15302462Read ↗

Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple MyelomaSemantic proximity Read ↗

Explaining racial differences in prostate cancer in the United States: sociology or biology?Semantic proximity Read ↗

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancerSemantic proximity Read ↗

Ethnic differences in prostate cancer.Semantic proximity Read ↗

Racial Differences in Androgen Receptor Protein Expression in Men With Clinically Localized Prostate CancerSemantic proximity Read ↗

Determinants of Black/White Differences in Colon Cancer SurvivalSemantic proximity Read ↗

Racial differences in CYP3A4 genotype and survival among men treated on Radiation Therapy Oncology Group (RTOG) 9202: a phase III randomized trial.Semantic proximity Read ↗

Trends in Survival Rates After Allogeneic Hematopoietic Stem-Cell Transplantation for Acute and Chronic Leukemia by Ethnicity in the United States and CanadaSemantic proximity Read ↗

Serum Androgen Levels in Black, Hispanic, and White MenSemantic proximity Read ↗

Racial differences in cancer of the male breast--15 year experience in the Detroit metropolitan area.Semantic proximity Read ↗

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.